Ewald N - Search Results

1

[Results of pancreatic surgery from the perspective of patients: a cross-sectional study of the support group "Arbeitskreis der Pankreatektomierten e. V."].

Dimopoulos I, Meyer G, Elhabash SI, Sorleto M, Gartung C, Ewald N, Fetzner UK, Otto L, Möhlenbrock F, Uhl W, Gerdes B. Dimopoulos I, et al. Among authors: ewald n. Z Gastroenterol. 2021 Mar;59(3):214-224. doi: 10.1055/a-1348-2680. Epub 2021 Jan 27. Z Gastroenterol. 2021. PMID: 33506450 German.

2

Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c).

Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Ewald N, et al. Diabetes Metab Res Rev. 2012 May;28(4):338-42. doi: 10.1002/dmrr.2260. Diabetes Metab Res Rev. 2012. PMID: 22121010

3

[Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data].

Ewald N, Toepler M, Akinci A, Kloer HU, Bretzel RG, Hardt PD. Ewald N, et al. Z Gastroenterol. 2005 Dec;43(12):1313-7. doi: 10.1055/s-2005-858657. Z Gastroenterol. 2005. PMID: 16315127 Review. German.

4

Predictive Value of Early Postoperative Course of Serum Cortisol After Transsphenoidal Surgery for Cushing's Disease.

Meier M, Alomari A, Feldkamp J, Mann WA, Santen R, Ewald N, Knappe UJ. Meier M, et al. Among authors: ewald n. Exp Clin Endocrinol Diabetes. 2022 Nov;130(11):704-713. doi: 10.1055/a-1909-1639. Epub 2022 Sep 9. Exp Clin Endocrinol Diabetes. 2022. PMID: 36084942 Free article.

5

The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis.

Duggan SN, Ewald N, Kelleher L, Griffin O, Gibney J, Conlon KC. Duggan SN, et al. Among authors: ewald n. Eur J Clin Nutr. 2017 Jan;71(1):3-8. doi: 10.1038/ejcn.2016.127. Epub 2016 Jul 13. Eur J Clin Nutr. 2017. PMID: 27406162 Review.

6

Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer.

Ewald N, Schaller M, Bayer M, Akinci A, Bretzel RG, Kloer HU, Hardt PD. Ewald N, et al. Anticancer Res. 2007 Jul-Aug;27(4A):1949-52. Anticancer Res. 2007. PMID: 17649802 Free article.

7

Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy.

Hardt PD, Ewald N. Hardt PD, et al. Among authors: ewald n. Expert Rev Mol Diagn. 2008 Sep;8(5):579-85. doi: 10.1586/14737159.8.5.579. Expert Rev Mol Diagn. 2008. PMID: 18785806

8

Pancreas divisum--an underestimated cause of chronic pancreatitis and relapsing episodes of acute pancreatitis?

Ewald N, Kloer HU, Bretzel RG, Hardt PD. Ewald N, et al. Dig Dis Sci. 2005 Oct;50(10):1857-9. doi: 10.1007/s10620-005-2951-8. Dig Dis Sci. 2005. PMID: 16187187 No abstract available.

9

Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial.

Ewald N, Bretzel RG, Fantus IG, Hollenhorst M, Kloer HU, Hardt PD; S-2453110 Study Group. Ewald N, et al. Diabetes Metab Res Rev. 2007 Jul;23(5):386-91. doi: 10.1002/dmrr.708. Diabetes Metab Res Rev. 2007. PMID: 17103488 Clinical Trial.

10

Determinants of Exocrine Pancreatic Function as Measured by Fecal Elastase-1 Concentrations (FEC) in Patients with Diabetes mellitus.

Ewald N, Raspe A, Kaufmann C, Bretzel RG, Kloer HU, Hardt PD. Ewald N, et al. Eur J Med Res. 2009 Mar 17;14(3):118-22. doi: 10.1186/2047-783x-14-3-118. Eur J Med Res. 2009. PMID: 19380282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters